Migraine therapy: Monoclonal antibodies block the calcitonin geen related receptor (CGRP)

https://youtu.be/CwZ23hoJ71w

The calcitonin gene related peptide (yellow) binds to its receptor (blue) on neurons and smooth muscle cells of cerebral blood vessels, activating a signal cascade through G-proteins (dark blue) in this cells, that leads to a dilatation of the blood vessels (vasodilatation). Blocking the CGRP receptor diminishes the quantity of migraine attacks.